KalVista Pharmaceuticals (KALV) Selling, General & Administrative (2014 - 2025)
KalVista Pharmaceuticals (KALV) Selling, General & Administrative (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | 101.25 Mn |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | 44.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 44.68 Mn |
| Apr 30, 2025 | 39.14 Mn |
| Oct 31, 2024 | 29.20 Mn |
| Jul 31, 2024 | 17.60 Mn |
| Apr 30, 2024 | 23.21 Mn |
| Jan 31, 2024 | 10.63 Mn |
| Oct 31, 2023 | 10.66 Mn |
| Jul 31, 2023 | 9.79 Mn |
| Apr 30, 2023 | 7.78 Mn |
| Jan 31, 2023 | 6.88 Mn |
| Oct 31, 2022 | 7.81 Mn |
| Jul 31, 2022 | 8.13 Mn |
| Apr 30, 2022 | 7.60 Mn |
| Jan 31, 2022 | 6.95 Mn |
| Oct 31, 2021 | 6.06 Mn |
| Jul 31, 2021 | 5.85 Mn |
| Apr 30, 2021 | 6.17 Mn |
| Jan 31, 2021 | 3.56 Mn |
| Oct 31, 2020 | 3.63 Mn |
| Jul 31, 2020 | 3.28 Mn |